Evidence map›Paper›PMID 36926956›Full record

ArticleJournal of the American Heart Association2023

Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events.

Isaac Acquah, Kobina Hagan, Zulqarnain Javed, Mohamad B Taha, Javier Valero-Elizondo, Nwabunie Nwana, Tamer Yahya, Garima Sharma, Martha Gulati, Aziz Hammoud and 5 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Isaac AcquahCenter for Outcomes Research Houston Methodist Houston TX.ORCID 0000-0003-2554-7806
Kobina HaganCenter for Outcomes Research Houston Methodist Houston TX.ORCID 0000-0003-4964-1880
Zulqarnain JavedDivision of Health Disparities and Equity Research Center for Outcomes Research, Houston Methodist Houston TX.ORCID 0000-0002-4137-9198
Mohamad B TahaDivision of Cardiovascular Prevention and Wellness Houston Methodist DeBakey Heart and Vascular Center Houston TX.
Javier Valero-ElizondoCenter for Outcomes Research Houston Methodist Houston TX.
Nwabunie NwanaCenter for Outcomes Research Houston Methodist Houston TX.
Tamer YahyaDivision of Cardiovascular Prevention and Wellness Houston Methodist DeBakey Heart and Vascular Center Houston TX.
Garima SharmaCiccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD.ORCID 0000-0001-7254-2077
Martha GulatiDivision of Cardiology University of Arizona (Phoenix) Phoenix AZ.ORCID 0000-0003-0735-9756
Aziz HammoudWake Forest School of Medicine Winston Salem NC.ORCID 0000-0001-9563-7060
Michael D ShapiroSection of Cardiovascular Medicine Wake Forest School of Medicine Winston Salem NC.ORCID 0000-0002-9071-3287
Ron BlanksteinCardiovascular Imaging Program, Department of Medicine and Radiology Brigham and Women's Hospital Boston MA.
Michael J BlahaCiccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD.ORCID 0000-0001-5138-9683
Miguel Cainzos-AchiricaCenter for Outcomes Research Houston Methodist Houston TX.ORCID 0000-0002-8073-2337
Khurram NasirCenter for Outcomes Research Houston Methodist Houston TX.ORCID 0000-0001-5376-2269

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
SUBCLINICAL CARDIOVASCULAR DISEASE COORDINATING CENTER-N01HC95159-268095159N01HC095159 · HC · UNIVERSITY OF WASHINGTON · PI KRONMAL, RICHARD A · 1999 to 2006
$304k
NCATS NIH HHS UL1 TR001881NHLBI NIH HHS HHSN268201500003CNHLBI NIH HHS HHSN268201500003INHLBI NIH HHS N01 HC095159
6 · The paper itself

Abstract

Background Although there is research on the impact of social determinants of health (SDOHs) on cardiovascular health, most existing evidence is based on individual SDOH components. We evaluated the impact of cumulative SDOH burden on cardiovascular risk factors, subclinical atherosclerosis, and incident cardiovascular disease events. Methods and Results We included 6479 participants from the MESA (Multi-Ethnic Study of Atherosclerosis). A weighted aggregate SDOH score representing the cumulative number of unfavorable SDOHs, identified from 14 components across 5 domains (economic stability, neighborhood and physical environment, community and social context, education, and health care system access) was calculated and divided into quartiles (quartile 4 being the least favorable). The impact of cumulative SDOH burden on cardiovascular risk factors (hypertension, diabetes, dyslipidemia, smoking, and obesity), systemic inflammation, subclinical atherosclerosis, and incident cardiovascular disease was evaluated. Increasing social disadvantage was associated with increased odds of all cardiovascular risk factors except dyslipidemia. Smoking was the risk factor most strongly associated with worse SDOH (odds ratio [OR], 2.67 for quartile 4 versus quartile 1 [95% CI, 2.13-3.34]). Participants within SDOH quartile 4 had 33% higher odds of increased high-sensitivity C-reactive protein (OR, 1.33 [95% CI, 1.11-1.60]) and 31% higher risk of all cardiovascular disease (hazard ratio, 1.31 [95% CI, 1.03-1.67]), yet no greater burden of subclinical atherosclerosis (OR, 1.01 [95% CI, 0.79-1.29]), when compared with those in quartile 1. Conclusions Increasing social disadvantage was associated with more prevalent cardiovascular risk factors, inflammation, and incident cardiovascular disease. These findings call for better identification of SDOHs in clinical practice and stronger measures to mitigate the higher SDOH burden among the socially disadvantaged to improve cardiovascular outcomes.

Indexed as

AtherosclerosisCardiovascular DiseasesHeart Disease Risk FactorsHumansInflammationRisk FactorsSocial Determinants of Healthcardiovascular diseasedisparitiesequityrisk factorssocial determinants of health

Identifiers

PMID36926956
PMCPMC10111542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.